We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, a... Rafael Holdings includes commercial real estate assets and interests in two clinical-stage pharmaceutical companies backed by a strong and liquid balance sheet. Rafael's real estate holdings are comprised by a 20-story commercial office building and associated parking garage in Newark, New Jersey, an office/data center building in Piscataway, New Jersey and an office condominium in Israel. Rafael's pharmaceutical holdings include interests in two clinical-stage oncology companies - Rafael Pharmaceuticals and LipoMedix. Rafael Pharmaceuticals is developing therapies that exploit the metabolic differences between normal cells and cancer cells in both solid and liquid cancers. LipoMedix is developing liposomal prodrugs designed to enhance the efficacy of certain chemotherapeutic therapies. Show more
NEWARK, N.J., June 14, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the third quarter and the first nine months of fiscal 2024 ended April...
TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and clinical outcomes for the treatment of Niemann-Pick Disease Type C1...
Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a...
| Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.01 | 0.689655172414 | 1.45 | 1.53 | 1.42 | 24367 | 1.46215946 | CS |
| 4 | -0.11 | -7.00636942675 | 1.57 | 1.74 | 1.42 | 18073 | 1.51943319 | CS |
| 12 | -0.25 | -14.6198830409 | 1.71 | 1.89 | 1.42 | 18001 | 1.62538985 | CS |
| 26 | -0.35 | -19.3370165746 | 1.81 | 1.95 | 1.42 | 22766 | 1.72324738 | CS |
| 52 | -0.75 | -33.9366515837 | 2.21 | 2.52 | 1.42 | 29737 | 1.79505617 | CS |
| 156 | -43.54 | -96.7555555556 | 45 | 66.44 | 1.42 | 145500 | 9.53553213 | CS |
| 260 | -16.89 | -92.0435967302 | 18.35 | 66.44 | 1.42 | 109626 | 11.89125289 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
